Effect of lactoferrin-embedded collagen membrane on osteogenic differentiation of human osteoblast-like cells

Journal of Bioscience and Bioengineering

Volumn 107, Issue 2, 2009, Pages 191-195

  Takayama, Yoshiharu ^a   Mizumachi, Koko ^a  

^a NATIONAL INSTITUTE OF LIVESTOCK AND GRASSLAND SCIENCE   (Japan)

Author keywords

Collagen membrane; Differentiation; Drug delivery system; Lactoferrin; Osteoblasts

Indexed keywords

ALKALINE PHOSPHATASE ACTIVITIES; BONE TISSUE ENGINEERINGS; BONE-LIKE TISSUES; BURST RELEASE; CALCIUM DEPOSITIONS; DIFFERENTIATION; DRUG DELIVERY CARRIERS; DRUG DELIVERY SYSTEM; GROWTH FACTORS; HUMAN OSTEOBLAST-LIKE CELLS; IN CELLS; LACTOFERRIN; MG63 CELLS; OSTEOCALCIN; OSTEOGENIC; OSTEOGENIC DIFFERENTIATIONS; POTENTIAL UTILITIES; TARGET SITES; TYPE I COLLAGENS;

BIOMINERALIZATION; BONE; CALCIUM; COLLAGEN; DRUG DELIVERY; MEMBRANES; OSTEOBLASTS; TISSUE ENGINEERING;

CELL MEMBRANES;

ALKALINE PHOSPHATASE; ANIMALS; CALCIUM; CATTLE; CELL DIFFERENTIATION; COLLAGEN; DRUG CARRIERS; HUMANS; LACTOFERRIN; MEMBRANES, ARTIFICIAL; OSTEOBLASTS; OSTEOCALCIN;

BOVINAE;

EID: 60949099012     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2008.09.018     Document Type: Article

References (35)

1. Muschler G.F., Nakamoto C., and Griffith L.G. Engineering principles of clinical cell-based tissue engineering. J. Bone Joint Surg., Am. 86 (2004) 1541-1548
2. Lee C.H., Singla A., and Lee Y. Biomedical applications of collagen. Int. J. Pharm. 221 (2001) 1-22
3. Rose F.R., and Oreffo R.O. Bone tissue engineering: hope vs hype. Biochem. Biophys. Res. Commun. 292 (2002) 1-7
4. Kofron M.D., Li X., and Laurencin C.T. Protein- and gene-based tissue engineering in bone repair. Curr. Opin. Biotechnol. 15 (2004) 399-405
5. Mackie E.J. Osteoblasts: novel roles in orchestration of skeletal architecture. Int. J. Biochem. Cell Biol. 35 (2003) 1301-1305
6. Lynch M.P., Stein J.L., Stein G.S., and Lian J.B. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp. Cell Res. 216 (1995) 35-45
7. García A.J., and Reyes C.D. Bio-adhesive surfaces to promote osteoblast differentiation and bone formation. J. Dent. Res. 84 (2005) 407-413
8. Jikko A., Harris S.E., Chen D., Mendrick D.L., and Damsky C.H. Collagen integrin receptors regulate early osteoblast differentiation induced by BMP-2. J. Bone Miner. Res. 14 (1999) 1075-1083
9. Salasznyk R.M., Williams W.A., Boskey A., Batorsky A., and Plopper G.E. Adhesion to vitronectin and collagen I promotes osteogenic differentiation of human mesenchymal stem cells. J. Biomed. Biotechnol. 1 (2004) 24-34
10. Hirata K., Mizuno A., and Yamaguchi A. Transplantation of skin fibroblasts expressing BMP-2 contributes to the healing of critical-sized bone defects. J. Bone Miner. Metab. 25 (2007) 6-11
11. King G.N. The importance of drug delivery to optimize the effects of bone morphogenetic proteins during periodontal regeneration. Curr. Pharm. Biotechnol. 2 (2001) 131-142
12. Takayama S., Murakami S., Shimabukuro Y., Kitamura M., and Okada H. Periodontal regeneration by FGF-2 (bFGF) in primate models. J. Dent. Res. 80 (2001) 2075-2079
13. Kimoto T., Hosokawa R., Kubo T., Maeda M., Sano A., and Akagawa Y. Continuous administration of basic fibroblast growth factor (FGF-2) accelerates bone induction on rat calvaria-an application of a new drug delivery system. J. Dent. Res. 77 (1998) 1965-1969
14. Street J., Bao M., deGuzman L., Bunting S., Peale Jr. F.V., Ferrara N., Steinmetz H., Hoeffel J., Cleland J.L., Daugherty A., and other 3 authors. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 9656-9661
15. Andreadis S.T., and Geer D.J. Biomimetic approaches to protein and gene delivery for tissue regeneration. Trends Biotechnol. 24 (2006) 331-337
16. Saltzman W.M., and Olbricht W.L. Building drug delivery into tissue engineering. Nat. Rev., Drug Discov. 1 (2002) 177-186
17. Murata M., Maki F., Sato D., Shibata T., and Arisue M. Bone augmentation by onlay implant using recombinant human BMP-2 and collagen on adult rat skull without periosteum. Clin. Oral Implants Res. 11 (2000) 289-295
18. Nakagawa T., and Tagawa T. Ultrastructural study of direct bone formation induced by BMPs-collagen complex implanted into an ectopic site. Oral Dis. 6 (2000) 172-179
19. Brock J.H. The physiology of lactoferrin. Biochem. Cell. Biol. 80 (2002) 1-6
20. Cornish J., Palmano K., Callon K.E., Watson M., Lin J.M., Valenti P., Naot D., Grey A.B., and Reid I.R. Lactoferrin and bone; structure-activity relationships. Biochem. Cell. Biol. 84 (2006) 297-302
21. Sato H., Kitazawa H., Adachi I., and Horikoshi I. Microdialysis assessment of microfibrous collagen containing a P-glycoprotein-mediated transport inhibitor, cyclosporine A, for local delivery of etoposide. Pharm. Res. 13 (1996) 1565-1569
22. Takezawa T., Takeuchi T., Nitani A., Takayama Y., Kino-Oka M., Taya M., and Enosawa S. Collagen vitrigel membrane useful for paracrine assays in vitro and drug delivery systems in vivo. J. Biotechnol. 131 (2007) 76-83
23. Matsumoto A., Yamaji K., Kawanami M., and Kato H. Effect of aging on bone formation induced by recombinant human bone morphogenetic protein-2 combined with fibrous collagen membranes at subperiosteal sites. J. Periodontal Res. 36 (2001) 175-182
24. Billiau A., Edy V.G., Heremans H., Van Damme J., Desmyter J., Georgiades J.A., and De Somer P. Human interferon: mass production in a newly established cell line, MG-63. Antimicrob. Agents Chemother. 12 (1977) 11-15
25. Bonewald L.F., Kester M.B., Schwartz Z., Swain L.D., Khare A., Johnson T.L., Leach R.J., and Boyan B.D. Effects of combining transforming growth factor beta and 1,25-dihydroxyvitamin D3 on differentiation of a human osteosarcoma (MG-63). J. Biol. Chem. 267 (1992) 8943-8949
26. Takagishi Y., Kawakami T., Hara Y., Shinkai M., Takezawa T., and Nagamune T. Bone-like tissue formation by three-dimensional culture of MG63 osteosarcoma cells in gelatin hydrogels using calcium-enriched medium. Tissue Eng. 12 (2006) 927-937
27. Takayama Y., and Mizumachi K. Effect of bovine lactoferrin on extracellular matrix calcification by human osteoblast-like cells. Biosci. Biotechnol. Biochem. 72 (2008) 226-230
28. Gundberg C.M. Biochemical markers of bone formation. Clin. Lab. Med. 20 (2000) 489-501
29. Vlodavsky I., and Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J. Clin. Invest. 108 (2001) 341-347
30. van Berkel P.H., Geerts M.E., van Veen H.A., Mericskay M., de Boer H.A., and Nuijens J.H. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem. J. 328 (1997) 145-151
31. Shimazaki K., Tazume T., Uji K., Tanaka M., Kumura H., Mikawa K., and Shimo-Oka T. Properties of a heparin-binding peptide derived from bovine lactoferrin. J. Dairy Sci. 81 (1998) 2841-2849
32. Yamamoto M., Ikada Y., and Tabata Y. Controlled release of growth factors based on biodegradation of gelatin hydrogel. J. Biomater. Sci., Polym. Ed. 12 (2001) 77-88
33. Trif M., Guillen C., Vaughan D.M., Telfer J.M., Brewer J.M., Roseanu A., and Brock J.H. Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases. Exp. Biol. Med. 226 (2001) 559-564
34. Thomas L.L., Xu W., and Ardon T.T. Immobilized lactoferrin is a stimulus for eosinophil activation. J. Immunol. 169 (2002) 993-999
35. Cheng S.L., Yang J.W., Rifas L., Zhang S.F., and Avioli L.V. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134 (1994) 277-286